Abstract:An increasing body of evidence suggests that gut microbiota is involved in atopic dermatitis (AD). We aimed to use high‐throughput sequencing to characterize the differences in the composition of the gut microbiota between healthy controls and patients with AD. Fecal samples from 93 volunteers were analyzed using 16S rRNA sequencing, including 44 patients with AD and 49 healthy control subjects, aged 6–22 years. Our data show that the operational taxonomic unit composition in patients with AD had greater component similarity than the healthy controls. Patients with AD had a lower alpha diversity than healthy control subjects. The relative abundance of Porphyromonadaceae, Blautia, Parabacteroides, Bacteroides ovatus, Bacteroides uniformis and Prevotella stercorea was significantly higher (P < 0.05) in patients with AD than healthy control subjects. Clostridium and P. stercorea were higher (P < 0.05) in healthy control subjects compared with patients with AD. The results of linear discriminant analysis effect size show that Bacteroidaceae and Porphyromonadaceae can act as possible biomarkers associated with diagnosis of AD. However, this needs further experimental verification. Taken together, these results demonstrate the changes in microbiota composition in AD compared with a healthy control group, opening the way to future diagnosis or intervention studies.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to analyze the differences in gut microbiota composition between atopic dermatitis (AD) patients and healthy controls in the Chinese population through high - throughput sequencing technology. Specifically, the study aims to: 1. **Characterize differences**: Use 16S rRNA sequencing technology to characterize the differences in gut microbiota composition between AD patients and healthy controls. 2. **Diversity analysis**: Evaluate the α - diversity and β - diversity between AD patients and healthy controls to understand the differences in species richness and evenness between the two groups of samples. 3. **Functional difference analysis**: Analyze the functional differences of the gut microbiota to understand its role in AD. 4. **Potential biomarkers**: Identify biomarkers that may be related to AD diagnosis through linear discriminant analysis effect size (LEfSe) analysis. ### Research background Atopic dermatitis is a chronic inflammatory skin disease, manifested as severe itching and recurrent eczema. In recent years, more and more evidence has shown that the gut microbiota is involved in the regulation of various physiological processes, such as cell proliferation, tissue morphogenesis, metabolism, and immune development and function. Changes in the gut microbiota may play a key role in the development of AD, especially in infancy and early childhood. ### Research methods - **Research subjects and sampling**: 44 AD patients and 49 healthy controls were recruited, aged between 6 and 22 years old. None of the subjects had received antibiotic treatment within 3 months before fecal sample collection. - **DNA extraction and library construction**: DNA was extracted using the E.Z.N.A. Stool DNA Kit and sequenced using the HiSeq 2500 system. - **Data analysis**: Filter the raw data to obtain clean reads, and then perform OTU clustering, taxonomic assignment, α - diversity and β - diversity analysis, and LEfSe analysis. ### Main results - **OTU composition**: The OTU composition of AD patients has a higher component similarity than that of healthy controls. - **α - diversity**: The α - diversity of AD patients is significantly lower than that of healthy controls, as manifested by a significant decrease in the Shannon index and a significant increase in the Simpson index. - **Species composition and abundance**: There are significant differences between AD patients and healthy controls at the phylum, class, order, family, genus, and species levels. For example, the relative abundances of Porphyromonadaceae, Blautia, Parabacteroides, Bacteroides ovatus, Bacteroides uniformis, and Prevotella stercorea are significantly higher in AD patients, while the relative abundances of Clostridium and Prevotella stercorea are higher in healthy controls. - **Potential biomarkers**: LEfSe analysis shows that Bacteroidaceae and Porphyromonadaceae may be potential biomarkers related to AD diagnosis. ### Discussion This study is the first to use high - throughput sequencing technology to analyze the differences in gut microbiota composition between AD patients aged 6 - 22 years old and healthy controls in the Chinese population. The results show that the gut microbiota diversity of AD patients is lower, and there are significant differences in the relative abundances of certain specific microbiota. These findings provide a basis for further diagnosis or intervention studies.

Diversity analysis of gut microbiota between healthy controls and those with atopic dermatitis in a Chinese population

Changes in oral, skin, and gut microbiota in children with atopic dermatitis: a case-control study

Unique Gut Microbiome Signatures among Adult Patients with Moderate to Severe Atopic Dermatitis in Southern Chinese

Characteristics of gut microbiota and serum metabolism in patients with atopic dermatitis

Identification of Candidate Genes in Atopic Dermatitis Based on Bioinformatic Methods

Multi-omics analyses reveal interactions between the skin microbiota and skin metabolites in atopic dermatitis

Comparison of Gut Viral Communities in Atopic Dermatitis and Healthy Children

Alterations in Gut Microbiome Associated with Severity of Atopic Dermatitis in Infants

The Difference of Gut Microbiota and Their Correlations With Urinary Organic Acids Between Autistic Children With and Without Atopic Dermatitis

Differential changes in the gut microbiota between extrinsic and intrinsic atopic dermatitis

Altered Microbiomes Distinguish Alzheimer's Disease from Amnestic Mild Cognitive Impairment and Health in a Chinese Cohort.

Gut Microbiota, Probiotics, and Their Interactions in Prevention and Treatment of Atopic Dermatitis: A Review

Microbial perspective on the skin–gut axis and atopic dermatitis

Comparative Analysis of the Microbiome across the Gut–Skin Axis in Atopic Dermatitis

Patho‐immunological mechanisms of atopic dermatitis: The role of the three major human microbiomes

Altered Gut Microbiota Composition Associated with Eczema in Infants

Comparative Analysis of Cutaneous Fungi in Atopic Dermatitis Patients and Healthy Individuals

Investigating Distinct Skin Microbial Communities and Skin Metabolome Profiles in Atopic Dermatitis

High-throughput Sequencing Analysis of Gut Microbiome in Patients with Severe Acne Vulgaris and Healthy Individuals

The skin microbiome in pediatric atopic dermatitis and food allergy

Characterization of Distinct Microbiota Associated with Scalp Dermatitis in Patients with Atopic Dermatitis